| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
SVP, Chief Tech. Ops. Officer | SVP, Quality, Gmp, Ops, It | Sr VP, Quality, Gmp Oper. &It
1 company
Mottola Frank serves as a SVP, Chief Tech. Ops. Officer at SUPN. Across recent SEC filings that breaks down to 0 buys and 8 sells.
Historically, Mottola Frank's trades have earned a below-average insider score of 43/100 across 6 rated trades. Over a 12-month horizon, 33.3% of those trades were profitable, with an average 12-month return of -18.8%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 9, 2026 | SUPN Supernus Pharmaceuticals, Inc. | SVP, Chief Tech. Ops. Officer | Sale+OE | 1,623 | $53.65 | $87,073.95 | -8.1% | -17.9% | - | |
| Dec 19, 2025 | SUPN Supernus Pharmaceuticals, Inc. | SVP, Chief Tech. Ops. Officer | Sale+OE10b5-1 | 20,000 | $50.41 | $1,008,150.00 | -56.3% | -5.1% | - | |
| Sep 12, 2025 | SUPN Supernus Pharmaceuticals, Inc. | SVP, Chief Tech. Ops. Officer | Sale+OE | 5,000 | $45.87 | $229,350.00 | -24.4% | +2.3% | -8.4% | |
| Aug 25, 2025 | SUPN Supernus Pharmaceuticals, Inc. | SVP, Quality, Gmp, Ops, It | Sale+OE | 14,000 | $44.51 | $623,140.00 | -47.5% | +1.6% | +2.1% | |
| Nov 7, 2024 | SUPN Supernus Pharmaceuticals, Inc. | SVP, Quality, Gmp, Ops, It | Sale+OE | 15,000 | $36.98 | $554,700.00 | -64.7% | +8.5% | +26.4% | |
| Nov 14, 2023 | SUPN Supernus Pharmaceuticals, Inc. | SVP, Quality, Gmp, Ops, It | Sale+OE | 1,110 | $28.13 | $31,224.30 | -16.3% | +1.1% | +34.7% | |
| Mar 14, 2023 | SUPN Supernus Pharmaceuticals, Inc. | Sr VP, Quality, Gmp Oper. &It | Sell | 4,780 | $35.99 | $172,022.64 | -50.2% | -6.5% | -4.7% |